These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Somatostatin--paracrine and neuromodulator peptide in gut and nervous system. Pimstone BL; Berelowitz M S Afr Med J; 1978 Jan; 53(1):7-9. PubMed ID: 25488 [TBL] [Abstract][Full Text] [Related]
29. Somatostatin--physiological and pathophysiological aspects. Schusdziarra V Scand J Gastroenterol Suppl; 1983; 82():69-84. PubMed ID: 6138852 [TBL] [Abstract][Full Text] [Related]
31. Rebound effect after somatostatin treatment in Verner-Morrison syndrome. Bonfils S; René E; Pignal F; Rambaud JC Lancet; 1979 Sep; 2(8140):476. PubMed ID: 89540 [No Abstract] [Full Text] [Related]
32. [Somatostatin: its physiological importance and use in the internal disease clinic (a review of the literature)]. Alekseev IuP Probl Endokrinol (Mosk); 1977; 23(6):93-106. PubMed ID: 341118 [No Abstract] [Full Text] [Related]
33. Clinical applications of somatostatin. del Pozo E Horm Res; 1988; 29(2-3):89-91. PubMed ID: 2900204 [TBL] [Abstract][Full Text] [Related]
35. [Somatostatin--its practical use in diseases of the digestive tract]. Paradowski L Wiad Lek; 1986 Mar; 39(5):330-4. PubMed ID: 2873690 [No Abstract] [Full Text] [Related]
36. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage? Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590 [No Abstract] [Full Text] [Related]
37. [Effect of somatostatin on the digestive tract functions]. Dwornicki M Przegl Lek; 1990; 47(8):593-6. PubMed ID: 1980955 [No Abstract] [Full Text] [Related]
38. [Somatostatin in the treatment of pancreatic diseases]. Németh AM Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869 [TBL] [Abstract][Full Text] [Related]
39. The use of somatostatin and its analogs in the treatment of surgical disorders. Mulvihill S; Pappas TN; Passaro E; Debas HT Surgery; 1986 Sep; 100(3):467-76. PubMed ID: 2874618 [TBL] [Abstract][Full Text] [Related]
40. Hypothesis: physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitus. Unger RH; Ipp E; Schusdziarra V; Orci L Life Sci; 1977 Jun; 20(12):2081-5. PubMed ID: 329036 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]